Blocking a newly identified memory pathway could prevent the disorder
About 8 million Americans suffer from nightmares and flashbacks to a traumatic event. This condition, known as post-traumatic stress disorder (PTSD), is particularly common among soldiers who have been in combat, though it can also be triggered by physical attack or natural disaster.
Studies have shown that trauma victims are more likely to develop PTSD if they have previously experienced chronic stress, and a new study from MIT may explain why. The researchers found that animals who underwent chronic stress prior to a traumatic experience engaged a distinctive brain pathway that encodes traumatic memories more strongly than in unstressed animals.
Blocking this type of memory formation may offer a new way to prevent PTSD, says Ki Goosens, the senior author of the study, which appears in the journal Biological Psychiatry.
“The idea is not to make people amnesic but to reduce the impact of the trauma in the brain by making the traumatic memory more like a ‘normal,’ unintrusive memory,” says Goosens, an assistant professor of neuroscience and investigator in MIT’s McGovern Institute for Brain Research.
The paper’s lead author is former MIT postdoc Michael Baratta.
Goosens’ lab has sought for several years to find out why chronic stress is so strongly linked with PTSD. “It’s a very potent risk factor, so it must have a profound change on the underlying biology of the brain,” she says.
To investigate this, the researchers focused on the amygdala, an almond-sized brain structure whose functions include encoding fearful memories. They found that in animals that developed PTSD symptoms following chronic stress and a traumatic event, serotonin promotes the process of memory consolidation. When the researchers blocked amygdala cells’ interactions with serotonin after trauma, the stressed animals did not develop PTSD symptoms. Blocking serotonin in unstressed animals after trauma had no effect.
“That was really surprising to us,” Baratta says. “It seems like stress is enabling a serotonergic memory consolidation process that is not present in an unstressed animal.”
Memory consolidation is the process by which short-term memories are converted into long-term memories and stored in the brain. Some memories are consolidated more strongly than others. For example, “flashbulb” memories, formed in response to a highly emotional experience, are usually much more vivid and easier to recall than typical memories.
Goosens and colleagues further discovered that chronic stress causes cells in the amygdala to express many more 5-HT2C receptors, which bind to serotonin. Then, when a traumatic experience occurs, this heightened sensitivity to serotonin causes the memory to be encoded more strongly, which Goosens believes contributes to the strong flashbacks that often occur in patients with PTSD.
“It’s strengthening the consolidation process so the memory that’s generated from a traumatic or fearful event is stronger than it would be if you don’t have this serotonergic consolidation engaged,” Baratta says.
“This study is a very nice dissection of the mechanism by which chronic stress seems to activate new pathways not seen in unstressed animals,” says Mireya Nadal-Vicens, medical director of the Center for Anxiety and Traumatic Stress Disorders at Massachusetts General Hospital, who was not part of the research team.
This memory consolidation process can take hours to days to complete, but once a memory is consolidated, it is very difficult to erase. However, the findings suggest that it may be possible to either prevent traumatic memories from forming so strongly in the first place, or to weaken them after consolidation, using drugs that interfere with serotonin.
“The consolidation process gives us a window in which we can possibly intervene and prevent the development of PTSD. If you give a drug or intervention that can block fear memory consolidation, that’s a great way to think about treating PTSD,” Goosens says. “Such an intervention won’t cause people to forget the experience of the trauma, but they might not have the intrusive memory that is ultimately going to cause them to have nightmares or be afraid of things that are similar to the traumatic experience.”
The Food and Drug Administration has already approved a drug called agomelatine that blocks this type of serotonin receptor and is used as an antidepressant.
Such a drug might also be useful to treat patients who already suffer from PTSD. These patients’ traumatic memories are already consolidated, but some research has shown that when memories are recalled, there is a window of time during which they can be altered and reconsolidated. It may be possible to weaken these memories by using serotonin-blocking drugs to interfere with the reconsolidation process, says Goosens, who plans to begin testing that possibility in animals.
The findings also suggest that the antidepressant Prozac and other selective serotonin reuptake inhibitors (SSRIs), which are commonly given to PTSD patients, likely do not help and may actually worsen their symptoms. Prozac enhances the effects of serotonin by prolonging its exposure to brain cells. While this often helps those suffering from depression, “There’s no biological evidence to support the use of SSRIs for PTSD,” Goosens says.
Read more: Possible new weapon against PTSD
The Latest on: PTSD Cure
via Google News
The Latest on: PTSD Cure
- Former Defence chief calls for rescheduling of psychedelic drugs to treat mental illness, PTSDon March 3, 2021 at 3:06 pm
A retired admiral says psilocybin – found in "magic mushrooms" – and MDMA can treat mental illness more effectively than commonly prescribed pills, but health authorities disagree.
- Group of House lawmakers fights for greater access to service dogs for veterans with PTSDon March 3, 2021 at 3:05 pm
A group of House lawmakers are reigniting calls to expand access to service dogs for veterans suffering from post-traumatic stress disorder amid a growing number of studies that show the treatment ...
- New Advanced Brain + Body Clinic Provides Hope for Treatment-Resistant Depression in Minneapolis Areaon March 3, 2021 at 5:52 am
Advanced Brain + Body Clinic (AB+BC) is a new interventional psychiatric clinic opening in Minnetonka, MN. Developed by psychiatrists Stephen Manlove, M.D. and Brian Johns, M.D., this new clinic will ...
- Does the brain change after therapy? UT researcher finds differences in scans after PTSD treatmenton March 3, 2021 at 5:13 am
Have you ever wondered if psychotherapy does anything physically to the brain to help people who have experienced trauma? Greg Fonzo, Dell Medical School assistant professor in th ...
- How poetry therapy can help you tap your creative side to overcome depression, PTSD, and moreon March 2, 2021 at 10:48 am
Poetry therapy uses poems, stories, song lyrics, imagery, and more to help people overcome a range of conditions including suicidal thoughts.
- Freespira's Digital Therapeutic Now Available to Help Adolescents With Panic Attacks, Panic Disorder and PTSDon March 2, 2021 at 5:20 am
Freespira, Inc., maker of the first FDA-cleared digital therapeutic to significantly reduce or eliminate symptoms of panic attacks, panic disorder and post-traumatic stress disorder (PTSD) in only 28 ...
- Innovative therapeutic program helps those living with PTSDon March 1, 2021 at 6:51 am
Millions of people live with post-traumatic stress disorder (PTSD), a mental health condition that develops in the aftermath of traumatic events. People with PTSD have difficulty in many aspects of ...
- A New Observational Study Focusing On Cannabis For PTSD Treatment Has Been Approvedon February 28, 2021 at 6:35 pm
The Battle Brothers Foundation has received approval to launch an observational study on the use of medical cannabis to help combat PTSD in veterans.
- Desmond inquiry: psychiatrist says soldier with PTSD had no treatment for four yearson February 23, 2021 at 9:25 am
An inquiry investigating why a former soldier killed three family members and himself in 2017 heard today from the psychiatrist who first diagnosed Lionel Desmond with post-traumatic stress disorder.
- One-Third of COVID Survivors May Have PTSDon February 18, 2021 at 9:01 am
Among the 381 patients who were followed, those who developed PTSD were more likely to be women (55.7%), had higher rates of history of psychiatric disorder (34.8%), and were more likely to have had ...
via Bing News